<p><strong>Gapping down</strong></p><p><u>In reaction to disappointing earnings/guidance:</u> ANW -41.5% (also downgraded to Hold from Buy at Lazard), SRDX -21.8%, CSCO -17.1% (also downgraded by multiple analysts), RST -9.7% (light volume), KLIC -7.2%, DAR -5.2% (light volume), CNQR -4.2% (also downgraded to Mkt Perform at Morgan Keegan), HMIN -1.4%, TEF -1.3%.</p><p><u>Select financial related names showing weakness</u>: IRE -7.6%, RBS -5.2% (weakness attributed to concerns on loans to Ireland), SFI -3.9%, ING -3.5%, NBG -3.3%, STD -3.1%, BCS -3.0%, BBVA -2.5%, DB -2.3%, CS -2.2%, UBS -2.0%, LYG -1.8%, HBC -1.4%, BAC -1.4%, RF -1.4%, HBAN -1.4%, C -1.2%.</p><p><u>CSCO peers and cos with CSCO exposure are under pressure:</u> JNPR -9.0%, CAVM -7.5%, ALU -5.4%, ALTR -5.4%, JBL -5.3% (downgraded to Hold from Buy at Citigroup), NETL -5.0%, FLEX -4.3% (downgraded to Hold from Buy at Citigroup), XLNX -4.0%, MRVL -3.8%, FFIV -3.6%, STM -3.4%, BRCM -3.3%, CIEN -3.0%, ASML -3.0%, JDSU -2.7%, QQQQ -1.4%.</p><p><u>Other news:</u> CNAM -18.2% (Jiangsu Province extends power restrictions to meet annual central government energy usage targets into the Q4, further impacting China Armco's Operations), ASTI -10.1% (intends to commence an underwritten public offering of its common stock), RINO -6.7% (comments on Muddy Waters allegations), CETV -6.0% (ticking lower; traded lower overseas following news that it will be removed from the MSCI Czech Republic Index ), CLNE -6.0% (prices of its public offering of 3 mln shares of its common stock at a price of $13.25 per share), OPTR -5.7% (disclosed it is voluntarily terminating the research study on Pruvel), STXS -5.0% (announced a common stock offering pursuant to its existing shelf registration), FUQI -4.3% (files to delay 10-Q), SUPG -3.7% (discontinues clinical development of SGI-1776), WPI -3.6% (announces commencement of secondary offering by selling stockholder), GLP -2.7% (announces public offering of common units), MITI -2.6% (announces the sale of common stock), BKH -2.4% (prices 4 mln shares of common stock at $29.75), CSGP -2.4% (still checking), RSH -1.6% (ticking lower; weakness attributed to tier 1 firm downgrade), PRU -1.4% (commenced a public offering of $1.0 billion of its common stock).</p><p><u>Analyst comments</u>: FTR -1.8% (downgraded to Market Perform from Strong Buy at Raymond James ), AA -1.6% (downgraded to Market Perform from Outperform at BMO Capital), JBLU -1.3% (downgraded to Hold from Buy at Citigroup).</p><p><strong>Gapping up</strong></p><p><u>In reaction to strong earnings/guidance</u>: OPTC +46.8% (thinly traded), GRRF +17.4%, WYY +9.3% (thinly traded), FTK +6.9%, UEPS +4.8% (clarifies guidance and reiterates its guidance of EPS of at least $1.50 vs. $1.55 consensus), BRKS +3.9%, TOD +3.7% (thinly traded), BT +3.2%, AAP +3.1%, AU +2.9%, VIA.B +2.0% (light volume), SI +1.9%, KSS +1.4%.</p><p><u>Other news</u>: LVLT +9.2% (Netflix signs multi-year deal with Level 3 for streaming services), DNDN +6.2% (strength attributed to positive report on Provenge; co submits post-approval supplement to the PROVENGE Biologics License Application for New Jersey manufacturing facility), IR +4.0% (will replace Pactiv in the S&P 500 index), HT +2.5% (Cramer makes positive comments on MadMoney), BVN +2.1% (ticking higher; strength attributed to tier 1 firm upgrade), DRYS +1.9% (subsidiary has received a Letter of Intent for the Eirik Raude from a British exploration co; contract value is ~$77 mln), WFR +1.7% (Cramer makes positive comments on MadMoney), DV +1.6% (raises dividend by 20% and authorizes additional share repurchases of up to $50 mln).</p>